Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
-.--% | -.--% |
2021 | Amryt Pharma to Delist from LSE's Main Market in January 2022 | MT |
2021 | Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase | MT |
End-of-day quotes
Sector
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio |
---|